BioHealth News Archive

Emergent BioSolutions to Acqui – GuruFocus.com

Emergent BioSolutions to Acqui – GuruFocus.com

GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (: EBS) announced today that it has entered into a definitive agreement with…

Read More
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate

Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate

GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for…

Read More
NIH seeks industry partners for technology transfer

NIH seeks industry partners for technology transfer

The National Institutes of Health (NIH) is the world's largest public funder of biomedical research, investing more than $30 billion in taxpayer dollars. However,…

Read More
The North American Subnational Innovation Competitiveness Index | ITIF

The North American Subnational Innovation Competitiveness Index | ITIF

The North American innovation ecosystem is increasingly diverse. In collaboration with Macdonald-Laurier Institute, Fundación IDEA, and the Bay Area Economic Council Institute, ITIF compiled…

Read More
Alexandria Real Estate Equities, Inc. Celebrates the Grand Opening of Alexandria LaunchLabs at Columbia to Accelerate the Commercialization of Novel Translational Science to Meet Significant Unmet Medical Needs

Alexandria Real Estate Equities, Inc. Celebrates the Grand Opening of Alexandria LaunchLabs at Columbia to Accelerate the Commercialization of Novel Translational Science to Meet Significant Unmet Medical Needs

NEW YORK, June 22, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…

Read More
Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy – Bloomberg

Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy – Bloomberg

Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single…

Read More
Aledade Raises $123 Million Series E to Accelerate Growth

Aledade Raises $123 Million Series E to Accelerate Growth

BETHESDA, Md., June 06, 2022 (GLOBE NEWSWIRE) -- Today, Aledade announced it has closed a $123 million Series E funding round to support investments in…

Read More
BioHealth Innovation is seeking a Senior Life Sciences Business Strategist (2)

BioHealth Innovation is seeking a Senior Life Sciences Business Strategist (2)

BioHealth Innovation, Inc., (BHI) is a regional non-profit innovation intermediary, which facilitates the development of growth-stage biohealth companies by connecting commercially relevant research assets…

Read More
Emergent BioSolutions Announces Publication of CHIKV VLP

Emergent BioSolutions Announces Publication of CHIKV VLP

GAITHERSBURG, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that two-year persistence data from its phase 2 clinical study…

Read More
New Mountain Capital Announces Growth Partnership with Emmes

New Mountain Capital Announces Growth Partnership with Emmes

Partnership to Support Emmes' Next Phase of Tech-Enabled Growth NEW YORK and ROCKVILLE, Md., June 21, 2022 /PRNewswire/ -- New Mountain Capital, a leading…

Read More

Maryland Inno – USM creates new pilot program to invest $600,000 in early stage startups

The University System of Maryland this week approved a new pilot program to fund early-stage startups. The measure, which was approved by the USM…

Read More
BioHealth Innovation is seeking a Senior Life Sciences Business Strategist

BioHealth Innovation is seeking a Senior Life Sciences Business Strategist

BioHealth Innovation, Inc., (BHI) is a regional non-profit innovation intermediary, which facilitates the development of growth-stage biohealth companies by connecting commercially relevant research assets…

Read More
How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on July 20th and find out. To sign-up for any of the EIR dates in 2022, please follow this link.

How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on July 20th and find out. To sign-up for any of the EIR dates in 2022, please follow this link.

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…

Read More
Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute

Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute

Treatment of Precursor Lesions Was Found to Significantly Reduce the Risk of Progression to Anal Cancer, with Study Result Highlighted in the New England…

Read More
MDUFA V – progress!

MDUFA V – progress!

  WASHINGTON, D.C. – The Senate Health, Education, Labor and Pensions Committee today passed S. 4348, the Food and Drug Administration Safety and Landmark…

Read More